estrogen and antiestrogen Flashcards
physiological function of estrogen
1) breast prolif.
2) bone integrity.
3) follice maturation
4) uterine growth
5) HDL increased, LDL decrease and TAG increase
6) anabolic effect: weight gain.
7) pro-coagulation.
8) increased stress and sympathetic activity.
9) secondary and primary growth.
natural estrogen
1) estradiol, estrone and estriol.
2) phytoestrogen
3) equine estrogen
synthetic estrogen, steroid-
ethinylestradiol, mestranol, quinestrol
synthetic estrogen, non-steroid
benzestrol, methestrol, hexestrol, dienestrol .diethylstilbestrol and more.
indications
1) hormone replacement therapy:
A) primary hypogonadism
B) post menopause- hot flashes and vaginal atrophy.
2)estrogen progestins:
Dysmenorrhea, amenorrhea and hirsutism, contraceptives,
Osteoporosis.
kinetics:
natural steroid- high first pass metabolism- given transdermal, intravaginal (Cream tablet, ring), injection.
synthetic- good oral bioavailability.
hormones bind to albumin.
metabolized and exreted in urine
adverse-
1) weight gain and acne and hyperpigmentation
2) increased thromboembolic risk
3) cancer- breast and endometrial
4) postmenopausal bleeding
5) headache, breast-tender.
6) GI- cholestasis, gallbladder disease and hepatic adenoma.
diethylstilbestrol (DES)
vaginal carcinoma, taken off.
contra
- pregnancy.
- estrogen dependent cancer.
- liver disease.
- thromboembolic past events.
- undiagonsed genital bleed.
SERMS-
Tamoxifen-breast cancer,
raloxifen- breast cancer and osteoporsis (agonist effect in bone), also no risk for endometrial cancer.
toremifene- breast cancer
clomiphene- fertility pill- partial estrogen agonist in the hypothalamus-> gnrh release-> ovulation.
ospemifene
used for painful intercourse
kinetics of SERMS
oral and then bile excretion
adverse of SERMS
1) increased risk for PE and DVT.
2) hot flashes, nausea.
3) increased risk for cancer- endometrial (raloxifene does not cause it but tamoxifene and toremifene do).
antiestrogens
fulvestrant- indicated for cancer resistant tamoxifene, given IV– estrogen receptor antagonist.
armomatase inhibitors- exemestane and formestane-
like fulvestrant